The Archer® FusionPlex® Solid Tumor Kit is a robust targeted sequencing assay to simultaneously detect and identify fusions and other mutations associated with over 50 genes linked to various carcinomas. This kit uses Archer’s proprietary Anchored Multiplex PCR (AMP™)-based enrichment to detect all fusions, even without prior knowledge of fusion partners or breakpoints.
Solid Tumor
AKT3 (V-akt murine thymoma viral oncogene homolog 3), ALK (Anaplastic lymphoma kinase), BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), ERG (ETS Transcription Factor ERG), ETV1 (ETS Variant Transcription Factor 1)
See More ...
Next-Generation Sequencing (NGS)